Erythropoietin-Deficient Anemia Associated with Autoimmune Polyglandular Syndrome Type I

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Autoimmune polyglandular syndrome type I (APS1), a relatively common disorder in some populations, is frequently associated with adrenal insufficiency, hypoparathyroidism, and other endocrine and skin abnormalities. We describe an 18-year-old male with APS1, as documented by genotyping, who presented with hypoparathyroidism and a normocytic, hypoproliferative, isolated anemia. An extensive hematological work-up revealed a low serum erythropoietin, without any other hematological abnormalities. His renal function was normal, and he did not have many of the laboratory or clinical findings associated with an anemia of chronic disease. His anemia was responsive to superphysiologic doses of erythropoietin. We thus suggest that erythropoietin deficiency may be one of the endocrine abnormalities associated with APS1, and clinicians should be cognizant of the association of treatable anemia in patients with APS1. © 2004 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Toonkel, R., Levine, M., & Gardner, L. (2004). Erythropoietin-Deficient Anemia Associated with Autoimmune Polyglandular Syndrome Type I. American Journal of Hematology, 75(2), 84–88. https://doi.org/10.1002/ajh.10441

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free